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Transoral robotic surgery (TORS) in 
South Africa
To the Editor: As members of a multidisciplinary team, we are extremely 
concerned about the da Vinci Transoral Robotic Surgery (TORS) 
advertisement that appeared in the SAMJ of September and November 
2016. It is misleading, makes false and unsubstantiated claims, and 
contravenes Health Professions Council of South Africa guidelines.
‘Minimisation or elimination of the need for chemoradiation 
therapy’ is a false statement. Combined therapy is determined by 
the disease process and staging, not by the surgery. TORS has no 
advantage over current transoral techniques in head and neck cancer 
management.
‘Avoidance of disfiguring mandibulotomy’: TORS has no advantage 
over current techniques that avoid mandibulotomy/mandibulectomy.
‘Quicker return to normal speech, swallowing and a full recovery’: 
there is no evidence that this is better than with proven transoral laser 
techniques.
‘Less blood loss and fewer transfusions’: there is no evidence that 
this is true compared with transoral laser and similar techniques.
‘Minimal scarring’: no evidence exists that scarring is less than 
with transoral laser techniques.
‘Avoidance of tracheostomy’: this has been demonstrated with 
transoral laser techniques, which have been in use for >20 years.
‘Less risk of infection’: there is no evidence that the risk of infection 
is less than when current techniques are used. Our team’s surgical 
complication rate is 3%, with only one wound infection in 497 head 
and neck cases.
‘Shortened hospital stay’: this has already occurred with the use of 
current transoral techniques. There is no evidence that TORS would 
shorten the hospital stay further.
There is no evidence that TORS has any advantage over current 
surgical management of head and neck tumours. 
Our team cannot currently support the use of TORS in head and 
neck cancer surgery.
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